The FDA has released a report on an investigation into imported honey and the intentional adulteration of it for economic gains.
The report from the Food and Drug Administration includes information on 107 samples from 25 countries. The FDA collected the samples in import status, which refers to products collected at ports of entry or other locations where they are held prior to being released into domestic commerce.
The agency tested retail and bulk samples in 2022 and 2023. Retail samples consisted of individual jars or other containers. Bulk shipment samples were collected typically from barrels or drums. All of the samples were labeled as being “honey.”
Here is the report: FY22/23 Sample Collection and Analysis of Imported Honey for Economically Motivated Adulteration.